One of The Largest Hedge Funds In The World Is Betting On Loxo Oncology Inc. (LOXO)

One of the largest hedge funds in the world is betting on Loxo Oncology Inc. (NASDAQ:LOXO), a biopharmaceuticals company that develops and sells medicine to treat certain types of cancer. Boston based Adage Capital disclosed a 1.35 million share position in Loxo Oncology. The hedge fund held only 817K shares of Loxo at the end of September. The details of the recent transactions are shared below:

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Adage Capital Partners 0 1,349,806 0 1,349,806 1,349,806 5.28%
Adage Capital Partners GP 0 1,349,806 0 1,349,806 1,349,806 5.28%
Adage Capital Advisors 0 1,349,806 0 1,349,806 1,349,806 5.28%
Robert Atchinson 0 1,349,806 0 1,349,806 1,349,806 5.28%
Phillip Gross 0 1,349,806 0 1,349,806 1,349,806 5.28%
Cancer Doctor pink ribbon cancer awareness hospital healthcare biotech

Copyright: wavebreakmediamicro / 123RF Stock Photo

Phill Gross And Robert Atchinson
Phill Gross And Robert Atchinson
Adage Capital Management

Page 1 of 11 – SEC Filing

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*

Loxo Oncology,
Inc.

(Name of Issuer)

Common Stock,
$0.0001 par value per share

(Title of Class of Securities)

548862101

(CUSIP Number)

December
28, 2016

(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
(Page 1 of 11 Pages)

______________________________

*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act“) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).

Follow Loxo Oncology Inc. (NASDAQ:LOXO)